Alnylam Pharmaceuticals Inc. (ALNY)

Market is closed

Insider Trading: Sales

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Fitzgerald Officer	$241.51	79	$19,079.29	12,684	2025-02-28	Filing
Fitzgerald Officer	$240.32	48	$11,535.36	12,763	2025-02-28	Filing
Fitzgerald Officer	$239.18	22	$5,261.96	12,811	2025-02-28	Filing
Fitzgerald Officer	$238.33	21	$5,004.93	12,833	2025-02-28	Filing
Fitzgerald Officer	$236.51	27	$6,385.77	12,854	2025-02-28	Filing
Greenstreet Officer, Director	$264.87	25	$6,621.75	81,526	2025-02-14	Filing
Greenstreet Officer, Director	$263.33	21	$5,529.93	81,551	2025-02-14	Filing
Greenstreet Officer, Director	$261.45	47	$12,288.15	81,572	2025-02-14	Filing
Greenstreet Officer, Director	$260.57	38	$9,901.66	81,619	2025-02-14	Filing
Greenstreet Officer, Director	$259.72	21	$5,454.12	81,657	2025-02-14	Filing
Greenstreet Officer, Director	$258.07	59	$15,226.13	81,678	2025-02-14	Filing
Greenstreet Officer, Director	$257.51	47	$12,102.97	81,737	2025-02-14	Filing
Greenstreet Officer, Director	$256.29	98	$25,116.42	81,784	2025-02-14	Filing
Greenstreet Officer, Director	$255.56	85	$21,722.60	81,882	2025-02-14	Filing
Greenstreet Officer, Director	$254.35	201	$51,124.35	81,967	2025-02-14	Filing
Greenstreet Officer, Director	$253.37	300	$76,011.00	82,168	2025-02-14	Filing
Greenstreet Officer, Director	$252.50	271	$68,427.50	82,468	2025-02-14	Filing
Poulton Officer	$264.87	20	$5,297.40	32,786	2025-02-14	Filing
Poulton Officer	$263.33	17	$4,476.61	32,806	2025-02-14	Filing
Poulton Officer	$261.45	37	$9,673.65	32,823	2025-02-14	Filing